Spineuro Meditech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.60 M
- Revenue Growth 51.55%
- Profit Growth 81.18%
- Ebitda 22.58%
- Net Worth 59.96%
- Total Assets 12.30%
About Spineuro Meditech
Spineuro Meditech Private Limited (SMPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 June 2015 (Nine years and eight months 0 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹0.60 M.
Vairamani Shanmugam, Annapoorani Rajan, and Saravanan Rajan serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900TN2015PTC100923
-
Company No.
100923
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Jun 2015
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Spineuro Meditech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vairamani Shanmugam
|
Director | 12-Jun-2015 | Current |
|
Annapoorani Rajan
|
Director | 12-Jun-2015 | Current |
|
Saravanan Rajan
|
Additional Director | 04-Nov-2020 | Current |
Financial Performance of Spineuro Meditech.
Spineuro Meditech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 51.55% increase. The company also saw a substantial improvement in profitability, with a 81.18% increase in profit. The company's net worth Soared by an impressive increase of 59.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spineuro Meditech?
In 2023, Spineuro Meditech had a promoter holding of 25.00% and a public holding of 75.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Medyssey India Private LimitedVairamani Shanmugam and Saravanan Rajan are mutual person
Charges (Loans)
₹0.60 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Dec 2020 | Hdfc Bank Limited | ₹0.60 M | Open |
How Many Employees Work at Spineuro Meditech?
Unlock and access historical data on people associated with Spineuro Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spineuro Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spineuro Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.